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Germline coding de novo mutations (SNVs, indels as
well as CNVs) are an important cause of moderate to
severe forms of intellectual disability (ID) and associated
syndromes. Exome sequencing now allows us to reliably
identify these mutations using a single genomic test, and
we have recently implemented exome sequencing in the
diagnostic follow-up of these patients.
In this presentation, I will first discuss the role of de
novo mutations in genetic disease and the associated risk
factors such as local genomic structure and paternal age.
Next, I will describe our recent work using a diagnostic
family-based exome sequencing approach to test this de
novo mutation hypothesis in 100 patients with unex-
plained ID, as well as targeted follow-up studies of several
candidate ID genes in 750 additional patients. A total of
79 unique coding de novo mutations were identified and
validated in 52 patients. Damaging de novo (n = 10) as
well as X-linked maternally-inherited (n = 3) mutations
were detected in known ID genes, resulting in a minimal
diagnostic yield of 13% in this cohort. In addition, poten-
tially causative de novo mutations in novel candidate ID
genes were detected in 22 patients. For three of these can-
didate genes, recurrent de novo mutations were identified
in patients with similar phenotypes, confirming that they
are true ID genes. To further expand the possibilities of
exome sequencing for mutation detection, we have
recently implemented automatic CNV detection on exome
data, and compared its performance to that of high-resolu-
tion genomic microarrays. This analysis shows that exome
sequencing can reliably detect the large majority of patho-
genic de novo CNVs, responsible for approximately 15%
of ID.
In conclusion, de novo mutations therefore represent an
important cause of ID, and exome sequencing is an effec-
tive diagnostic strategy for their detection.
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